Related Experiment Video
Updated: Mar 7, 2026

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Nasopharyngeal adenocarcinoma: A population-based analysis
Edward C Kuan1, Jose E Alonso1, Armin Arshi2
1Department of Head and Neck Surgery, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, United States.
Nasopharyngeal adenocarcinoma is a rare cancer with a generally poor prognosis. However, younger age, lower tumor grade, and surgical treatment are associated with improved survival outcomes.
Area of Science:
- Oncology
- Epidemiology
- Cancer Research
Background:
- Nasopharyngeal adenocarcinoma is an extremely rare malignancy.
- Limited data exists on its incidence and survival trends.
Purpose of the Study:
- To describe the incidence and survival determinants of nasopharyngeal adenocarcinoma.
- Utilize the Surveillance, Epidemiology, and End Result (SEER) database for analysis.
Main Methods:
- Retrospective cohort study using the SEER national database (1973-2012).
- Analysis of patient data including histopathology, demographics, stage, grade, and treatment.
- Calculation of overall survival (OS) and disease-specific survival (DSS).
Main Results:
- 148 cases of nasopharyngeal adenocarcinoma identified; median OS was 60.6 months.
- Survival rates at 2, 5, and 10 years were 63%, 49%, and 36%, respectively.
- Younger age, surgery, combined surgery and radiation, and lower tumor grade were associated with improved OS and DSS.
Conclusions:
- Nasopharyngeal adenocarcinoma has a poor prognosis, with the papillary subtype being an exception.
- Age, tumor grade, and surgical therapy are significant predictors of survival.
- Further research into rare head and neck cancers is warranted.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023